Technology Videos

Sean Spencer, MD, PhD, Fellow ’20, Postdoc ’22 | Harnessing Gut Microbes to Heal Patients

Dr. Sean Spencer, a Stanford gastroenterologist and physician‑scientist, presented the emerging clinical frontier of gut‑microbe therapeutics. He outlined how advances in sequencing, culturing and sampling are moving the microbiome from a research curiosity to a practical diagnostic and therapeutic tool. Three convergent technologies—"decode" (rapid stool metagenomic sequencing), "grow" (culturomics that can culture nearly any gut organism) and "probe" (ingestible capsules that sample the entire GI tract)—now allow clinicians to map, isolate, and interrogate microbial communities with unprecedented resolution. These tools turn the gut’s 500,000 genes and trillions of cells into actionable data within days. Spencer highlighted antibiotic‑induced dysbiosis as a clear clinical problem, using cases of C. difficile infection, resistant bloodstream infections, and post‑transplant complications. He traced the evolution from historic fecal enemas to modern fecal microbiota transplantation, noting the FDA’s recent approval of two microbiome‑restoration drugs for recurrent C. difficile. The talk underscored a paradigm shift: instead of merely killing pathogens, physicians must restore a balanced microbial ecosystem. Defined microbial consortia, engineered probiotics, and metabolite‑based “drugs from bugs” represent the next wave of scalable, regulated therapies that could reshape gastroenterology and broader disease management.